Clinical studies & Posters

Science icon

2024

Perceptual Learning Therapy Improves Vision & Contrast Sensitivity in Amblyopia Related with Post-CXL Keratoconus & MF-IOLs: Pooled Analysis

 

2024

Prospective Open-Label Randomized Controlled Clinical Study Evaluating the Efficacy of Perceptual Learning in Improving Vision among Patients with Congenital Nystagmus – AAPOS 2024

 

2024

ASCRS 2024 Best Poster Award: RCT Results of Perceptual Amblyopia Therapy for Improving Vision & Contrast Sensitivity Functions in Crosslinked Stable Keratoconus

 

2023

AAPOS 2023: Improving Vision and Binocularity in Older Children and Adults with Amblyopia and Nystagmus

 

2011

AAO 2011: Two – Year Results of NeuroVision Treatment in Adult Patients with Unilateral Amblyopia


2011

Visual Acuity and Contrast Sensitivity Improvement in Cases of Congenital Nystagmus Using NeuroVision™ (RevitalVision LLC.) Technology: A Retrospective Multinational Multicenter Case Series. 2011.

 

2011

Case Report: 83 Year Old Wet AMD Patient Successfully Treated with NeuroVision (RevitalVision LLC.)

 

2011

ESCRS: Efficacy of neural vision therapy to enhance visual acuity and contrast sensitivity function in Amblyopia

 

2010

ARVO: Evaluation of Computer-Based Primary Visual Cortex Training After Aspheric Monofocal, Multifocal, and Accommodating IOL Implantation 

 

2009

ASCRS: Neuroplasticity Key to Vision Recovery – efficacy in improving vision in patients with Retinitis Pigmentosa (RP)Keratoconus patients following intra-stromal corneal ring, and following cataract surgery with Multi-Focal IOL replacement.

 

2008

AAO: NeuroVision treatment of unilateral Amblyopia in patients older than 9 years

 

2008

AAO: A randomized controlled trial evaluating the efficacy of neurovision’s neural vision correction technology in enhancing unaided visual acuity in adults with Low Myopia

 

2008

IMC: 2 Years follow-up results of visual acuity and contrast sensitivity enhancement in patients with Low Myopia using NeuroVision neural vision correction technology

 

2007

AAO: Efficacy of NeuroVision technology in enhancing unaided vision in early Presbyopes and Low Myopes

 

2007

ASIA ARVO: Cortical enhancement of Habitual VA of subjects using Neural Vision Correction Technology

 

2007

AAO: A randomized controlled trial evaluating the efficacy of neural vision correction technology in enhancing unaided visual acuity in Low Myopes

 

2007

ARVO: Enhancement of undercorrected visual acuity and contrast sensitivity in Myopic Children using NeuroVision’s neural vision correction technology

2006

APAO: Improving VA and CSF in subjects with low degree of Myopia and early Presbyopia using neural vision correction technology

 

2005

AAO: What is still lacking in Refractive Surgery is the role of neuroprocessing

 

2005

ASIA ARVO: The alternative approach to visual blur: NeuroVision treatment for Myopia, Post-Refractive Surgery and Presbyopia

2005

ARVO: Improving CSF in subjects with a Low degree of Myopia using neural vision correction technology

 

2004

ARVO: Pilot study to evaluate the efficacy of neural vision correction technology for vision improvement in Low Myopia

 

Contact Us



    Talshir Medical Technologies LTD
    Hama’ayan Street 2, Modi’in 7177871, Israel
    USA Office: 1.800.361.8218 | Main Office: +972.77.212.3272

    info@revitalvision.com
    Contact background